Create your Personal Health Record and unlock support built around you
- Treatments and trials you qualify for
- Education for your stage of care
- Financial support for your medications
- Solutions to your side effects
Lymphocyte Count Used to Predict Delayed Neurotoxicity in Myeloma CAR-T | Hitomi Hosoya MD #ims25
HealthTreeDescription
Lymphocyte counts may help predict delayed neurotoxicity in patients receiving CAR-T cell therapy for multiple myeloma. In this HealthTree presentation from the International Myeloma Society (IMS) 2025 Annual Meeting (#IMS25), Hitomi Hosoya, MD, shares research findings on how monitoring lymphocyte levels could guide physicians in identifying patients at higher risk of late-onset CAR-T related neurotoxicity.
🔔 Subscribe to HealthTree for more updates on CAR-T therapy, myeloma research, and patient education.
#Myeloma #CART #IMS25 #Neurotoxicity #CancerResearch #HealthTree
Watch the full course and our most up-to-date content here: https://linktr.ee/HealthTreeUniversity
Create a free account to track your progress, bookmark lessons, and keep up-to-date on the latest advancements in treating cancer!
Patients have the key to find cures for cancer. Learn more about HealthTree Cure Hub here: https://healthtree.org/curehub?utm_source=social+media&utm_medium=htu+youtube&utm_campaign=htu-curehub&utm_content=general
Educated and empowered patients have better outcomes. We've partnered with hundreds of medical experts and doctors to help you learn more about your disease.